Publications

2023 | Best Practice & Research. Clinical ...

Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: the mission-driven role of the National Marrow Donor Program

Authors:

Yusuf RA, Preussler JM, Meyer CL, Schoeppner K, Sees Coles JA, McCann M, Devine SM, Auletta JJ

2023 | Transplantation and Cellular Therapy

Impact of public reporting of Center-Specific Survival Analysis scores on Patient volumes at hematopoietic cell transplant centers.

Authors:

Sharma A, Logan B, Estrada-Merly N, Lehmann LE, Rangarajan HG, Preussler JM, Troy JD, Akard LP, Bhatt NS, Truong TH, Wood WA, Strouse C, Juckett M, Khera N, Rizzo D, Saber W

2023 | Blood Advances

A simple prognostic system in myelofibrosis patients undergoing allogeneic stem cell transplant: A CIBMTR/EBMT analysis.

Authors:

Tamari R, McLornan D, Ahn KW, Estrada-Merly N, Hernandez-Boluda JC, Giralt SA, Palmer JM, Gale RP, DeFilipp Z, Marks D, van der Poel MWM, Verdonck LF, Battiwalla M, Díaz MA, Gupta V, Ali H, Litzow MR, Lazarus HM, Gergis U, Bashey A, Liesveld JL, Hashmi S, Pu JJ, Beitinjaneh A, Bredeson CN, Rizzieri DA, Savani BN, Abid MB, Ganguly S, Agrawal V, Ulrike V, Wirk B, Jain T, Cutler C, Aljurf M, Kindwall-Keller T, Kharfan-Dabaja MA, Hildebrandt GC, Pawarode A, Solh MM, Yared JA, Grunwald MR, Nathan S, Nishihori T, Seo S, Scott BL, Nakamura R, Oran B, Czerw T, Yakoub-Agha I, Saber W

2023 | EClinicalMedicine

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: A prospective, multicentre, observational study.

Authors:

Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA

2023 | Blood Advances

Assessment of HLA-DPB1 genetic variation with an HLA-DP tool and implications in clinical transplantation.

Authors:

Sajulga R, Bolon YT, Maiers M, Petersdorf EW

2023 | Transplantation and Cellular Therapy

Cost-effectiveness of unrelated umbilical cord blood vs. HLA haploidentical related bone marrow transplant: evidence from BMT CTN 1101.

Authors:

Ramsey SD, Bansal A, Li L, O'Donnell PV, Fuchs EJ, Brunstein CG, Eapen M, Thao V, Roth JA, Steuten L

2023 | EClinicalMedicine

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.

Authors:

Hill J, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Shahid Z, Armistead P, Westervelt P, McCarty John, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales M-A

2023 | HLA

GRAMM: A new method for analysis of HLA in families.

Authors:

Ansbacher-Feldman Z, Israeli S, Maiers M, Gragert L, De Santis D, Israeli M, Louzoun Y

2023 | Transplantation and Cellular Therapy

Heath-related quality of life in double umbilical cord blood vs. haploidentical marrow transplantation: A QOL analysis report of BMT CTN 1101.

Authors:

El Jurdi N, Martens MJ, Brunstein CG, O'Donnell P, Lee SJ, D'Souza A, Logan B, Hong S, Singh AK, Sandhu K, Shapiro RM, Horowitz MM, Hamilton BK

2023 | American Journal of Hematology

Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.

Authors:

Jadi O, Tang H, Olsen K, Vensko S, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, Brock G, Webb A, Pasquini MC, McCarthy PL, Spellman SR, Hahn T, Vincent B, Armistead P, Sucheston-Campbell LE

2023 | Blood Advances

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced intensity conditioning HCT.

Authors:

Geerlink AV, Scull B, Krupski C, Fleischmann R, Pulsipher MA, Eapen M, Connelly JA, Bollard CM, Pai SY, Duncan C, Kean LS, Baker KS, Burroughs L, Andolina JR, Shenoy S, Roehrs P, Hanna R, Talano JA, Schultz KR, Stenger EO, Lin H, Zoref-Lorenz A, McClain KL, Jordan MB, Man TK, Allen CE, Marsh RA

2023 | Journal of Clinical Oncology

Reply to R. Meisel.

Authors:

Eapen M, Brazaukas R

2023 | Journal of Hematology & Oncology

Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: A CIBMTR study.

Authors:

Zhang T, Auer P, Dong J, Cutler C, Dezern AE, Gadalla SM, Deeg HJ, Nazha A, Carlson KS, Spellman S, Bolon YT, Saber W

2023 | HLA

World Marrow Donor Association guidelines for the reporting of novel HLA alleles.

Authors:

Hofmann JA, Bochtler W, Robinson J, Sauter J, Askar M, Houdova L, Melchers M, Schmidt AH, Spierings E, Urban C, Venter A, Maiers M, Marsh SGE, Eberhard HP

2023 | Blood Advances

Clinical Impact of Cryopreservation of Allogeneic Hematopoietic Cell Grafts During the Onset of the COVID-19 Pandemic.

Authors:

Devine SM, Bo-Subait S, Kuxhausen M, Spellman SR, Bupp C, Ahn KW, Stefanski HE, Auletta JJ, Logan BR, Shaw BE

2023 | Blood Reviews

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

Authors:

Juckett M, Dandoy C, DeFilipp, Kindwall-Keller TL, Spellman SR, Ustun C, Waldman BM, Weisdorf DJ, Wood WA, Horowitz MM, Burns LJ, Khera N

2023 | Cancer

Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.

Authors:

Bumma N, Dhakal B, Fraser R, Estrada-Merly N, Anderson K, Freytes CO, Hildebrandt GC, Holmberg L, Krem MM, Lee C, Lekakis L, Lazarus HM, Mian H, Murthy HS, Nathan S, Nishihori T, Parrondo R, Patel SS, Solh M, Strouse C, Vesole DH, Kumar S, Qazilbash M, Shah N, D'Souza A, Sidana S

2023 | HLA

Genomic characterization of HLA class I and class II genes in ethnically diverse sub-Saharan African populations: A report on novel HLA alleles.

Authors:

Pagkrati I, Duke JL, Mbunwe E, Mosbruger TL, Ferriola D, Wasserman J, Dinou A, Tairis N, Damianos G, Kotsopoulou I, Papaioannou J, Giannopoulos D, Beggs W, Nyambo T, Mpoloka SW, Mokone GG, Njamnshi AK, Fokunang C, Woldemeskel D, Belay G, Maiers M, Tishkoff SA, Monos DS

2023 | Transplantation and Cellular Therapy

HLA Class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated AML.

Authors:

Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman SR, Lee SJ

2023 | Transplantation and Cellular Therapy

Effect of autograft CD34+ dose on outcome in pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors.

Authors:

Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA